Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Frontiers in Plant Science|July 28, 2025
Engineering the moss <i>Physcomitrium patens</i> to produce proteins with paucimannosidic glycansJessica Jonner, Benjamin Fode, Jonas Koch, et al.Journal of Neuroinflammation|April 11, 2025
Moss-derived human complement factor H modulates retinal immune response and attenuates retinal degenerationMandy Hector, Verena Behnke, Paulina Dabrowska-Schlepp, et al.JIMD Reports|May 12, 2021
Uptake of moss-derived human recombinant GAA in <i>Gaa</i> <sup>-/-</sup> miceStefan Hintze, Paulina Dabrowska-Schlepp, Birgit Berg, et al.Frontiers in Immunology|March 24, 2025
Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3GTodor Tschongov, Swagata Konwar, Jessika Kleindienst, et al.International Journal of Molecular Sciences|April 16, 2020
Moss-Derived Human Recombinant GAA Provides an Optimized Enzyme Uptake in Differentiated Human Muscle Cells of Pompe DiseaseStefan Hintze, Sarah Limmer, Paulina Dabrowska-Schlepp, et al.JIMD Reports|November 6, 2023
Comparison of efficacy between subcutaneous and intravenous application of moss-aGal in the mouse model of Fabry diseasePaulina Dabrowska-Schlepp, Andreas Busch, Jin-Song Shen, et al.Frontiers in Immunology|July 16, 2026
<i>Moss-derived</i> recombinant Factor H, CPV-104, effectively antagonizes alternative pathway C3/C5 convertases stabilization by NeFs from patients with primary C3 glomerulopathyZahra Imanifard, Francesca Penati, Sofia Padoa, et al.Frontiers in Immunology|May 27, 2024
Moss-produced human complement factor H with modified glycans has an extended half-life and improved biological activityTodor Tschongov, Swagata Konwar, Andreas Busch, et al.Journal of Inherited Metabolic Disease|August 28, 2015
Mannose receptor-mediated delivery of moss-made α-galactosidase A efficiently corrects enzyme deficiency in Fabry miceJin-Song Shen, Andreas Busch, Taniqua S Day, et al.Pageof 1